Accelerated Development of Additive Pharmacotherapy Treatment (ADAPT-2) for Methamphetamine Use Disorder
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Madhukar Trivedi, MD
University of Texas Southwestern Medical Center
Principal InvestigatorKOL profile →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of California Los Angeles (ucla) Center for Behavioral Addiction Medicine (cbam)
Los Angeles, California, United States
- Substance Use Research Unit (suru) at the San Francisco Dept. of Public Health
San Francisco, California, United States
- Hennepin County Medical Center- Berman Center for Research
Minneapolis, Minnesota, United States
- New York State Psychiatric Institute (nyspi)- Substance Use Research Center (surc)
New York, New York, United States
- Coda, Inc.
Portland, Oregon, United States
- Behavioral Health Services (bhs) of Pickens County
Pickens, South Carolina, United States
- University of Texas Southwestern Medical Center
Dallas, Texas, United States
- University of Texas Health Science Center - Center for Neurobehavioral Research on Addiction (cnra)
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 5 May 2017
- Primary completion
- 3 Jul 2019
- Completion
- 25 Jul 2019
- Last update posted
- 3 May 2021
- Registered enrollment
- 403
- Registry id
- NCT03078075
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.